Achilles Therapeutics (ACHL) News Today → Pentagon contract could send this $2 AI stock soaring (From Behind the Markets) (Ad) Free ACHL Stock Alerts $0.79 +0.01 (+1.28%) (As of 04/24/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineComparing Achilles Therapeutics (NASDAQ:ACHL) & Entera Bio (NASDAQ:ENTX)americanbankingnews.com - April 21 at 1:26 AMAchilles Therapeutics plc - Depositary Receipt () (ACHL) Price Target Decreased by 56.41% to 2.89msn.com - April 17 at 2:25 PMAchilles Therapeutics plc (NASDAQ:ACHL) Sees Large Growth in Short Interestamericanbankingnews.com - April 16 at 4:44 AMPiper downgrades Achilles to neutral, cites latest datamsn.com - April 5 at 2:27 PMACHL Stock Earnings: Achilles Therapeutics Misses EPS for Q4 2023markets.businessinsider.com - April 4 at 1:23 PMAchilles Therapeutics PLC: Achilles Therapeutics Reports Fourth Quarter and Year-End 2023 Financial Results and Recent Business Highlightsfinanznachrichten.de - April 4 at 8:23 AMAchilles Therapeutics Reports Fourth Quarter and Year-End 2023 Financial Results and Recent Business Highlightsglobenewswire.com - April 4 at 6:45 AMAchilles Therapeutics Provides Interim Phase I/IIa Update on Clonal Neoantigen Reactive T Cells in Advanced NSCLC and Melanoma Including First Patients Dosed with Enhanced Host Conditioningglobenewswire.com - April 4 at 6:30 AMAchilles Therapeutics (ACHL) to Release Earnings on Tuesdaymarketbeat.com - April 1 at 1:43 AMWill Achilles Therapeutics (NASDAQ:ACHL) Spend Its Cash Wisely?finance.yahoo.com - March 7 at 1:42 PMAchilles Therapeutics (ACHL) Set to Announce Quarterly Earnings on Tuesdaymarketbeat.com - March 4 at 7:22 AMAchilles Therapeutics PLC ADRwsj.com - February 22 at 5:29 PMAchilles Therapeutics Stock (NASDAQ:ACHL), Short Interest Reportbenzinga.com - February 22 at 5:29 PMAchilles Therapeutics PLC ADR (ACHL)investing.com - February 9 at 6:38 PMAchilles Therapeutics to Present at the 10th Annual Immuno-Oncology 360 Conferencefinance.yahoo.com - February 5 at 8:25 AMAchilles Therapeutics Stock (NASDAQ:ACHL) Dividends: History, Yield and Datesbenzinga.com - December 22 at 12:49 AMACHL Achilles Therapeutics plcseekingalpha.com - December 20 at 6:06 PMAchilles Therapeutics Announces Publication of Nature Cancer ‘Comment’ on Strategy for Improved Neoantigen Immunogenicity Predictionfinance.yahoo.com - December 18 at 8:16 AMSteelers lose Kwon Alexander for season with torn Achilles: reportsfoxnews.com - November 22 at 12:45 AMAchilles Therapeutics GAAP EPS of -$0.42 misses by $0.02msn.com - November 14 at 8:14 AMAs Aaron Rodgers rehabs from torn Achilles, doctor offers insight into recoveryfoxnews.com - October 29 at 10:22 PMAchilles Therapeutics PLC: Achilles Therapeutics Receives Nasdaq Deficiency Notice Regarding Minimum Bid Price Requirementfinanznachrichten.de - September 23 at 6:51 AMAre Medical Stocks Lagging Achilles Therapeutics (ACHL) This Year?uk.style.yahoo.com - September 22 at 3:54 PMAaron Rodgers says he's starting 'road to recovery' after Achilles surgery went 'great'usatoday.com - September 21 at 9:03 AMJets QB Aaron Rodgers to miss rest of NFL season with torn Achillesusatoday.com - September 17 at 6:24 AMAaron Rodgers said he was 'manifesting' a Super Bowl run for the Jets in interview with John McEnroe that aired just MINUTES before he suffered season-ending Achilles injurydailymail.co.uk - September 14 at 8:17 PMAaron Rodgers' Achilles injury is "not good," Jets head coach says, as star quarterback is set to get MRIcbsnews.com - September 14 at 8:17 PMIs KalVista Pharmaceuticals (KALV) Stock Outpacing Its Medical Peers This Year?finance.yahoo.com - September 6 at 5:24 PMChardan Capital Reiterates Achilles Therapeutics Plc - ADR (ACHL) Buy Recommendationmsn.com - August 7 at 10:06 AMAchilles Therapeutics Reports Second Quarter 2023 Financial Results and Recent Business Highlightsfinance.yahoo.com - August 4 at 5:33 PMAchilles Therapeutics PLC: Achilles Therapeutics to Present at Upcoming Conferencesfinanznachrichten.de - June 12 at 7:17 PMAchilles Therapeutics: Q1 Earnings Insightsmsn.com - May 11 at 6:51 PMAchilles Therapeutics GAAP EPS of -$0.44seekingalpha.com - May 10 at 5:49 PMAchilles Therapeutics PLC: Achilles Therapeutics Reports First Quarter 2023 Financial Results and Recent Business Highlightsfinanznachrichten.de - May 10 at 12:48 PMAchilles Therapeutics’ New Immunogenicity Prediction Application of its AI-Powered PELEUS™ Platform Uniquely Identifies the Most Potent T Cell Antigensfinance.yahoo.com - May 10 at 7:48 AMAchilles Therapeutics Reports First Quarter 2023 Financial Results and Recent Business Highlightsfinance.yahoo.com - May 10 at 7:48 AMAchilles Therapeutics Receives Nasdaq Deficiency Notice Regarding Minimum Bid Price Requirementfinance.yahoo.com - April 25 at 9:08 PMAchilles Therapeutics Announces Grant of US Patent Covering the Treatment of Patients with an Immunotherapy Targeting Neoantigens Based on Tumor HLA Statusfinance.yahoo.com - April 25 at 10:50 AMAchilles Therapeutics to Present at Chardan’s 7th Annual Genetic Medicines and Cell Therapy Manufacturing Summitfinance.yahoo.com - April 17 at 8:05 AMGerard Achilles M. Obnialhealth.usnews.com - March 24 at 10:42 PMMe and my operation: achilles tendon surgerydailymail.co.uk - March 24 at 7:40 AMAchilles Therapeutics PLC: Achilles Therapeutics Reports Fourth Quarter and Year-End 2022 Financial Results and Recent Business Highlightsfinanznachrichten.de - March 7 at 11:09 AMAchilles Therapeutics Reports Fourth Quarter and Year-End 2022 Financial Results and Recent Business Highlightsfinance.yahoo.com - March 7 at 11:09 AMIs Anika Therapeutics (ANIK) Stock Outpacing Its Medical Peers This Year?finance.yahoo.com - January 17 at 1:12 PMAchilles Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conferencefinance.yahoo.com - December 20 at 1:12 PMAchilles Therapeutics Presents Encouraging Phase I/IIa Update on Clonal Neoantigen Reactive T Cells in Advanced NSCLC and Melanoma at ESMO IO Congress 2022finance.yahoo.com - December 6 at 8:48 AMAchilles Therapeutics to Present Early Proof of Concept of Safety and Clinical Activity of Clonal Neoantigen Reactive T Cells at the ESMO Immuno-Oncology Annual Congress 2022finance.yahoo.com - November 30 at 9:40 PMAchilles Therapeutics Announces Grant of US Patent on Immunotherapies Targeting Clonal Neoantigens Identified Using Proprietary Methodfinance.yahoo.com - November 22 at 7:38 PMIs Achilles Therapeutics (NASDAQ:ACHL) In A Good Position To Deliver On Growth Plans?finance.yahoo.com - November 13 at 1:48 PMAchilles Therapeutics Reports Third Quarter 2022 Financial Results and Recent Business Highlightsfinance.yahoo.com - November 8 at 11:20 AM Get Achilles Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for ACHL and its competitors with MarketBeat's FREE daily newsletter. Email Address Pentagon contract could send this $2 AI stock soaring (Ad)Whenever the Department of Defense awards a major AI contract... Early investors could see dramatic returns virtually overnight. That's how my readers were able to cash in gains like 133% in just four months on C3.ai... Get all the info here >>> ACHL Media Mentions By Week ACHL Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ACHL News Sentiment▼0.000.43▲Average Medical News Sentiment ACHL News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ACHL Articles This Week▼20▲ACHL Articles Average Week Get Achilles Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for ACHL and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: INKT News TARA News INAB News PLUR News CYTH News TVGN News NKGN News AIM News OKYO News EVAX News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ACHL) was last updated on 4/24/2024 by MarketBeat.com Staff From Our PartnersDid You Get Your Free Bitcoin Yet?Crypto Swap Profitstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressPentagon contract could send this $2 AI stock soaringBehind the MarketsDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersThe #1 Crypto for 2024InvestorPlaceEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest Metals Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Achilles Therapeutics plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
